P119: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD). (31st January 2022) - Bartolucci, P; Ataga, K; Callaghan, M; De Franceschi, L; Minniti, C; Alexandrou, A; Imbs, D; Fox, R; Patel, H; Sostelly, A; Schimmel, J